Celebrating 100 years of Immunology & Cell Biology – a special focus on the field of tumor immunology in Australia

IF 3.2 4区医学 Q3 CELL BIOLOGY

Immunology & Cell Biology Pub Date : 2023-09-11 DOI:10.1111/imcb.12690

Snehlata Kumari, Rachael M Zemek, Umaimainthan Palendira, Lisa M Ebert

引用次数: 1

Abstract

In this Commentary article, as part of the 100-year celebrations of the journal, we reflect on the contribution of articles published in ICB in the field of tumor immunology. A highlight is a series of interviews conducted with three Australian-based ICB authors who have contributed key papers over the years: Rajiv Khanna, Delia Nelson and Ian Frazer.

Abstract Image

查看原文本刊更多论文

庆祝100 免疫学和细胞生物学多年，特别关注澳大利亚肿瘤免疫学领域

在这篇评论文章中，作为该杂志百年庆典的一部分，我们回顾了发表在ICB上的文章在肿瘤免疫学领域的贡献。一个亮点是对三位澳大利亚洲际弹道导弹作者进行的一系列采访，他们多年来贡献了关键论文：Rajiv Khanna、Delia Nelson和Ian Frazer。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Immunology & Cell Biology 医学-免疫学

CiteScore

7.50

自引率

2.50%

发文量

审稿时长

4-8 weeks

期刊介绍： The Australasian Society for Immunology Incorporated (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.